Encompass Health (NYSE:EHC) CEO Mark Tarr Sells 150,000 Shares

Encompass Health Corporation (NYSE:EHC) CEO Mark Tarr sold 150,000 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total value of $16,746,000.00. Following the sale, the chief executive officer directly owned 377,070 shares in the company, valued at $42,096,094.80. This trade represents a 28.46% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Encompass Health Price Performance

EHC opened at $112.16 on Friday. The firm has a market capitalization of $11.29 billion, a PE ratio of 20.25, a price-to-earnings-growth ratio of 2.16 and a beta of 0.73. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.08 and a quick ratio of 1.14. The business’s 50-day moving average is $103.98 and its two-hundred day moving average is $114.47. Encompass Health Corporation has a 1 year low of $92.53 and a 1 year high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.29 by $0.17. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The business had revenue of $3.09 billion during the quarter, compared to analyst estimates of $1.54 billion. During the same period in the prior year, the firm posted $1.17 earnings per share. The company’s quarterly revenue was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Research analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Royal Bank of Canada lifted its holdings in shares of Encompass Health by 21.5% during the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after purchasing an additional 15,677 shares during the period. Millennium Management LLC boosted its holdings in shares of Encompass Health by 38.4% in the 1st quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock valued at $9,338,000 after acquiring an additional 25,574 shares during the last quarter. Caxton Associates LLP acquired a new stake in shares of Encompass Health in the first quarter worth $259,000. US Bancorp DE raised its holdings in shares of Encompass Health by 226.9% during the second quarter. US Bancorp DE now owns 7,737 shares of the company’s stock worth $949,000 after purchasing an additional 5,370 shares during the last quarter. Finally, Callan Family Office LLC acquired a new position in Encompass Health during the second quarter valued at $258,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

EHC has been the topic of a number of recent analyst reports. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Barclays increased their price target on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research note on Friday, February 6th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Finally, Zacks Research lowered shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $143.29.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.